Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?

Am J Respir Crit Care Med. 2022 May 1;205(9):988-990. doi: 10.1164/rccm.202201-0040ED.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Familial Primary Pulmonary Hypertension
  • Humans
  • Proteome
  • Proteomics
  • Pulmonary Arterial Hypertension* / diagnosis
  • Risk Assessment

Substances

  • Proteome